Cargando…

Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor

[Image: see text] Components of the chromatin remodelling switch/sucrose nonfermentable (SWI/SNF) complex are recurrently mutated in tumors, suggesting that altering the activity of the complex plays a role in oncogenesis. However, the role that the individual subunits play in this process is not cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martin, Laetitia J., Koegl, Manfred, Bader, Gerd, Cockcroft, Xiao-Ling, Fedorov, Oleg, Fiegen, Dennis, Gerstberger, Thomas, Hofmann, Marco H., Hohmann, Anja F., Kessler, Dirk, Knapp, Stefan, Knesl, Petr, Kornigg, Stefan, Müller, Susanne, Nar, Herbert, Rogers, Catherine, Rumpel, Klaus, Schaaf, Otmar, Steurer, Steffen, Tallant, Cynthia, Vakoc, Christopher R., Zeeb, Markus, Zoephel, Andreas, Pearson, Mark, Boehmelt, Guido, McConnell, Darryl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2016
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885110/ https://www.ncbi.nlm.nih.gov/pubmed/26914985 http://dx.doi.org/10.1021/acs.jmedchem.5b01865

Ejemplares similares

Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition
por: Hohmann, Anja F., et al.
Publicado: (2016)

Drugging an undruggable pocket on KRAS
por: Kessler, Dirk, et al.
Publicado: (2019)

Reply to Tran et al.: Dimeric KRAS protein–protein interaction stabilizers
por: Kessler, Dirk, et al.
Publicado: (2020)

LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor**
por: Clark, Peter G K, et al.
Publicado: (2015)

LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor
por: Clark, Peter G. K., et al.
Publicado: (2015)

BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design
por: Farnaby, William, et al.
Publicado: (2019)

Locking mixed-lineage kinase domain-like protein in its auto-inhibited state prevents necroptosis
por: Rübbelke, Martin, et al.
Publicado: (2020)

Discovery of Novel Small-Molecule Inhibitors of BRD4 Using Structure-Based Virtual Screening
por: Vidler, Lewis R., et al.
Publicado: (2013)

Preparation data of the bromodomains BRD3(1), BRD3(2), BRD4(1), and BRPF1B and crystallization of BRD4(1)-inhibitor complexes
por: Hügle, Martin, et al.
Publicado: (2016)

Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma
por: Brien, Gerard L, et al.
Publicado: (2018)

Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel–Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7
por: Zoppi, Vittoria, et al.
Publicado: (2018)

Molecular Basis of Histone Tail Recognition by Human TIP5 PHD Finger and Bromodomain of the Chromatin Remodeling Complex NoRC
por: Tallant, Cynthia, et al.
Publicado: (2015)

A small-molecule inhibitor of lectin-like oxidized LDL receptor-1 acts by stabilizing an inactive receptor tetramer state
por: Schnapp, Gisela, et al.
Publicado: (2020)

Designing Dual Inhibitors of Anaplastic Lymphoma Kinase (ALK) and Bromodomain-4 (BRD4) by Tuning Kinase Selectivity
por: Watts, Ellen, et al.
Publicado: (2019)

CBP/p300 Bromodomains Regulate Amyloid-like Protein Aggregation upon Aberrant Lysine Acetylation
por: Olzscha, Heidi, et al.
Publicado: (2017)

Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of small molecule inhibitor JQ1
por: Decker, Tim-Michael, et al.
Publicado: (2017)

BET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic β-Cell
por: Deeney, Jude T., et al.
Publicado: (2016)

Bromodomain-containing subunits BRD1, BRD2, and BRD13 are required for proper functioning of SWI/SNF complexes in Arabidopsis
por: Jarończyk, Kamila, et al.
Publicado: (2021)

BRD4 localization to lineage-specific enhancers is associated with a distinct transcription factor repertoire
por: Najafova, Zeynab, et al.
Publicado: (2017)

An Activity‐Based Probe Targeting Non‐Catalytic, Highly Conserved Amino Acid Residues within Bromodomains
por: D'Ascenzio, Melissa, et al.
Publicado: (2018)

Bromodomain Protein BRD4 Is Required for Estrogen Receptor-Dependent Enhancer Activation and Gene Transcription
por: Nagarajan, Sankari, et al.
Publicado: (2014)

BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis
por: Roberts, Thomas C., et al.
Publicado: (2017)

BRD4 promotes p63 and GRHL3 expression downstream of FOXO in mammary epithelial cells
por: Nagarajan, Sankari, et al.
Publicado: (2017)

tBRD-1 and tBRD-2 regulate expression of genes necessary for spermatid differentiation
por: Theofel, Ina, et al.
Publicado: (2017)

Increased expression of BRD4 isoforms long (BRD4-L) and short (BRD4-S) promotes chemotherapy resistance in high-grade serous ovarian carcinoma
por: Drumond-Bock, Ana Luiza, et al.
Publicado: (2023)

Effect of BET Missense Mutations on Bromodomain Function, Inhibitor Binding and Stability
por: Lori, Laura, et al.
Publicado: (2016)

Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF
por: Bennett, James, et al.
Publicado: (2015)

Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function
por: Cribbs, Adam P., et al.
Publicado: (2021)

Targeting BRD9 by I-BRD9 efficiently inhibits growth of acute myeloid leukemia cells
por: Zhou, Lixin, et al.
Publicado: (2021)

Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion
por: Liu, Yi, et al.
Publicado: (2023)

Identification and Development of 2,3-Dihydropyrrolo[1,2-a]quinazolin-5(1H)-one Inhibitors Targeting Bromodomains within the Switch/Sucrose Nonfermenting Complex
por: Sutherell, Charlotte L., et al.
Publicado: (2016)

Molecular dynamics simulations data of six compounds F3J-BRD4/CBP, EX1-BRD4/CBP, and E2T-BRD4/CBP
por: Wu, Shiliang, et al.
Publicado: (2021)

Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia (AML)
por: Herrmann, Harald, et al.
Publicado: (2012)

Emerging Roles of BRD7 in Pathophysiology
por: Park, Sang Won, et al.
Publicado: (2020)

Supercharging BRD4 with NUT in carcinoma
por: Eagen, Kyle P., et al.
Publicado: (2021)

BRD2 Compartmentalizes the Accessible Genome
por: Xie, Liangqi, et al.
Publicado: (2022)

Brd4‐Brd2 isoform switching coordinates pluripotent exit and Smad2‐dependent lineage specification
por: Fernandez‐Alonso, Rosalia, et al.
Publicado: (2017)

Theoretical exploration of the binding selectivity of inhibitors to BRD7 and BRD9 with multiple short molecular dynamics simulations
por: Wang, Lifei, et al.
Publicado: (2022)

Cloning BRD4 long isoform into overexpression vectors for stable overexpression of BRD4-L in mammalian cells
por: Drumond-Bock, Ana Luiza, et al.
Publicado: (2022)

Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRAS(G12C) Inhibitor
por: Bröker, Joachim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8l6ush92m8hferbpbc9sbr4u9j